Table 3.
Acute Care Metrics | 30-day mortality OR (95% CI)* | 6-month mortality OR (95% CI)* | 30-day readmissions OR (95% CI)* |
---|---|---|---|
rt-PA, arrive by 2 hrs and treat by 3 hrs | |||
White | 0.92 (0.43–1.99) | 0.92 (0.44–1.91) | 0.83 (0.45–1.55) |
Black | 0.25 (0.05–1.20) | ||
Hispanic | 0.93 (0.07–12.63) | 1.64 (0.19–13.95) | |
Early Antithrombotic Use | |||
White | 0.48 (0.34–0.67) | 0.55 (0.44–0.70) | 0.93 (0.72–1.21) |
Black | 0.98 (0.40–2.42) | 0.70 (0.42–1.15) | 0.60 (0.34–1.05) |
Hispanic | 0.79 (0.49–1.26) | 0.87 (0.61–1.24) | 0.97 (0.55–1.73) |
Antithrombotics at Discharge | |||
White | 0.38 (0.23–0.61) | 0.61 (0.40–0.91) | 1.03 (0.77–1.36) |
Black | 0.90 (0.46–1.78) | 0.57 (0.34–0.93) | 0.87 (0.45–1.65) |
Hispanic | 0.24 (0.10–0.59) | 0.44 (0.18–1.09) | 1.01 (0.54–1.89) |
Anticoagulation for Atrial Fibrillation | |||
White | 0.58 (0.29–1.18) | 0.83 (0.50–1.37) | 0.93 (0.57–1.51) |
Black | 0.35 (0.06–2.09) | 0.45 (0.13–1.53) | 0.90 (0.08–9.57) |
Hispanic | 1.31 (0.53–5.33) | 0.96 (0.48–1.92) | 3.40 (0.68–17.09) |
Smoking Cessation Counseling | |||
White | 1.77 (0.44–7.16) | 2.09 (0.68–6.42) | |
Black | 0.67 (0.17–2.68) | 0.29 (0.03–2.44) | |
Hispanic | 0.65 (0.04–10.30) | 0.32 (0.07–1.46) | |
LDL 100 or ND – Statin | |||
White | 0.60 (0.39–0.92) | 0.68 (0.51–0.90) | 0.92 (0.75–1.12) |
Black | 2.36 (0.74–7.55) | 0.86 (0.53–1.37) | 0.65 (0.42–0.99) |
Hispanic | 0.94 (0.58–1.52) | 1.12 (0.77–1.61) | 0.74 (0.46–1.20) |
VTE prophylaxis | |||
White | 0.96 (0.72–1.29) | 0.90 (0.72–1.12) | 1.01 (0.83–1.24) |
Black | 1.18 (0.63–2.19) | 1.04 (0.68–1.59) | 0.93 (0.64–1.35) |
Hispanic | 1.00 (0.70–1.43) | 1.07 (0.84–1.36) | 1.31 (0.84–2.04) |
Controlling for age, sex, and NIHSS (where results are missing the models did not converge)